학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 155건 | 목록 1~20
Academic Journal
In Biochimica et Biophysica Acta (BBA)/Protein Structure and Molecular Enzymology 2002 1594(2):297-306
Academic Journal
Kalin JH; Janssen Research & Development, LLC, a Johnson & Johnson Company, Spring House, Pennsylvania, USA.; Yin Y; Janssen Research & Development, LLC, a Johnson & Johnson Company, Spring House, Pennsylvania, USA.; Tran MT; Janssen Pharmaceutica N.V., Beerse, Belgium.; Piassek M; Janssen Research & Development, LLC, a Johnson & Johnson Company, Spring House, Pennsylvania, USA.; Fung A; Janssen Research & Development, LLC, a Johnson & Johnson Company, Brisbane, California, USA.; Grosse S; Janssen Pharmaceutica N.V., Beerse, Belgium.; Jacoby E; Janssen Pharmaceutica N.V., Beerse, Belgium.; Bhaumik A; Janssen Research & Development, LLC, a Johnson & Johnson Company, Spring House, Pennsylvania, USA.; Adhikary S; Janssen Research & Development, LLC, a Johnson & Johnson Company, Spring House, Pennsylvania, USA.; Miller R; Janssen Research & Development, LLC, a Johnson & Johnson Company, Spring House, Pennsylvania, USA.; Lemmens C; Janssen Pharmaceutica N.V., Beerse, Belgium.; Lutter FH; Janssen Pharmaceutica N.V., Beerse, Belgium.; Pieters S; Janssen Pharmaceutica N.V., Beerse, Belgium.; Cooymans L; Janssen Pharmaceutica N.V., Beerse, Belgium.; Rombouts G; Janssen Pharmaceutica N.V., Beerse, Belgium.; Oehlrich D; Janssen Pharmaceutica N.V., Beerse, Belgium.; Tomaso S; Janssen Research & Development, LLC, a Johnson & Johnson Company, Brisbane, California, USA.; Lozada K; Janssen Research & Development, LLC, a Johnson & Johnson Company, Brisbane, California, USA.; Garcia MO; Janssen Research & Development, LLC, a Johnson & Johnson Company, Brisbane, California, USA.; Anson B; Janssen Research & Development, LLC, a Johnson & Johnson Company, Brisbane, California, USA.; De Bruyn S; Janssen Pharmaceutica N.V., Beerse, Belgium.; Smith-Monroy C; Janssen Research & Development, LLC, a Johnson & Johnson Company, Spring House, Pennsylvania, USA.; Neefs J-M; Janssen Pharmaceutica N.V., Beerse, Belgium.; Conceição-Neto N; Janssen Pharmaceutica N.V., Beerse, Belgium.; Stoops B; Janssen Pharmaceutica N.V., Beerse, Belgium.; van Vlijmen H; Janssen Pharmaceutica N.V., Beerse, Belgium.; Patrick A; Janssen Research & Development, LLC, a Johnson & Johnson Company, Spring House, Pennsylvania, USA.; Yu X; Janssen Research & Development, LLC, a Johnson & Johnson Company, Spring House, Pennsylvania, USA.; Wong V; Janssen Research & Development, LLC, a Johnson & Johnson Company, Spring House, Pennsylvania, USA.; Krosky D; Janssen Research & Development, LLC, a Johnson & Johnson Company, Spring House, Pennsylvania, USA.; Abeywickrema P; Janssen Research & Development, LLC, a Johnson & Johnson Company, Spring House, Pennsylvania, USA.; Mason S; Janssen Research & Development, LLC, a Johnson & Johnson Company, Brisbane, California, USA.; Jin Z; Janssen Research & Development, LLC, a Johnson & Johnson Company, Brisbane, California, USA.; Jonckers THM; Janssen Pharmaceutica N.V., Beerse, Belgium.; Sharma S; Janssen Research & Development, LLC, a Johnson & Johnson Company, Spring House, Pennsylvania, USA.
Publisher: American Society For Microbiology Country of Publication: United States NLM ID: 0113724 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-5514 (Electronic) Linking ISSN: 0022538X NLM ISO Abbreviation: J Virol Subsets: MEDLINE
Academic Journal
Frikke-Schmidt H; Cardiovascular Metabolism, Retina and Pulmonary Hypertension, Janssen R&D, Spring House, Pennsylvania. Electronic address: hfrikkes@its.jnj.com.; Albarazanji K; Cardiovascular Metabolism, Retina and Pulmonary Hypertension, Janssen R&D, Spring House, Pennsylvania.; Qi J; Cardiovascular Metabolism, Retina and Pulmonary Hypertension, Janssen R&D, Spring House, Pennsylvania.; Frederick D; Cardiovascular Metabolism, Retina and Pulmonary Hypertension, Janssen R&D, Spring House, Pennsylvania.; Steffen J; Cardiovascular Metabolism, Retina and Pulmonary Hypertension, Janssen R&D, Spring House, Pennsylvania.; Kalyana-Sundaram S; Cardiovascular Metabolism, Retina and Pulmonary Hypertension, Janssen R&D, Spring House, Pennsylvania.; Meng R; Cardiovascular Metabolism, Retina and Pulmonary Hypertension, Janssen R&D, Spring House, Pennsylvania.; Devine ZH; Cardiovascular Metabolism, Retina and Pulmonary Hypertension, Janssen R&D, Spring House, Pennsylvania.; Chen T; Preclincial Sciences and Translational Safety, Janssen R&D, Shanghai, China.; Li Q; Cardiovascular Metabolism, Retina and Pulmonary Hypertension, Janssen R&D, Spring House, Pennsylvania.; Du F; Cardiovascular Metabolism, Retina and Pulmonary Hypertension, Janssen R&D, Spring House, Pennsylvania.; Ho G; Cardiovascular Metabolism, Retina and Pulmonary Hypertension, Janssen R&D, Spring House, Pennsylvania.; Liu J; Cardiovascular Metabolism, Retina and Pulmonary Hypertension, Janssen R&D, Spring House, Pennsylvania.; Riley R; Non-Clinical Safety Pathology, Janssen R&D, Spring House, Pennsylvania.; Gonzalez-Villalobos RA; Cardiovascular Metabolism, Retina and Pulmonary Hypertension, Janssen R&D, Spring House, Pennsylvania.; Camacho RC; Cardiovascular Metabolism, Retina and Pulmonary Hypertension, Janssen R&D, Spring House, Pennsylvania.; Nawrocki AR; Cardiovascular Metabolism, Retina and Pulmonary Hypertension, Janssen R&D, Spring House, Pennsylvania.; Pryor M; Therapeutics Discovery, Janssen R&D, Spring House, Pennsylvania.; Lee M; Therapeutics Discovery, Janssen R&D, Spring House, Pennsylvania.; Wong V; Therapeutics Discovery, Janssen R&D, Spring House, Pennsylvania.; Matico R; Therapeutics Discovery, Janssen R&D, Spring House, Pennsylvania.; Diaz E; Therapeutics Discovery, Janssen R&D, Spring House, Pennsylvania.; Krosky D; Therapeutics Discovery, Janssen R&D, Spring House, Pennsylvania.; Wall M; Discovery Chemistry, Janssen R&D, Spring House, Pennsylvania.; Gao E; Discovery Chemistry, Janssen R&D, Spring House, Pennsylvania.; Shah AA; Discovery Chemistry, Janssen R&D, Spring House, Pennsylvania.; Leonard J; Cardiovascular Metabolism, Retina and Pulmonary Hypertension, Janssen R&D, Spring House, Pennsylvania.; Erion M; Cardiovascular Metabolism, Retina and Pulmonary Hypertension, Janssen R&D, Spring House, Pennsylvania.; Pocai A; Cardiovascular Metabolism, Retina and Pulmonary Hypertension, Janssen R&D, Spring House, Pennsylvania.; Player MR; Discovery Chemistry, Janssen R&D, Spring House, Pennsylvania.
Publisher: Elsevier Country of Publication: Netherlands NLM ID: 0376362 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1521-0103 (Electronic) Linking ISSN: 00223565 NLM ISO Abbreviation: J Pharmacol Exp Ther Subsets: MEDLINE
Academic Journal
Balibar CJ; Infectious Disease and Vaccines, Merck & Co. Inc., Rahway, NJ 07065, USA.; Klein DJ; Computational and Structural Chemistry, Merck & Co. Inc., Rahway, NJ, 07065, USA.; Zamlynny B; Computational and Structural Chemistry, Merck & Co. Inc., Rahway, NJ, 07065, USA.; Diamond TL; Infectious Disease and Vaccines, Merck & Co. Inc., Rahway, NJ 07065, USA.; Fang Z; Infectious Disease and Vaccines, Merck & Co. Inc., Rahway, NJ 07065, USA.; Cheney CA; Infectious Disease and Vaccines, Merck & Co. Inc., Rahway, NJ 07065, USA.; Kristoff J; Infectious Disease and Vaccines, Merck & Co. Inc., Rahway, NJ 07065, USA.; Lu M; Infectious Disease and Vaccines, Merck & Co. Inc., Rahway, NJ 07065, USA.; Bukhtiyarova M; Quantitative Biosciences, Merck & Co. Inc., Rahway, NJ 07065, USA.; Ou Y; Quantitative Biosciences, Merck & Co. Inc., Rahway, NJ 07065, USA.; Xu M; Quantitative Biosciences, Merck & Co. Inc., Rahway, NJ 07065, USA.; Ba L; Quantitative Biosciences, Merck & Co. Inc., Rahway, NJ 07065, USA.; Carroll SS; Quantitative Biosciences, Merck & Co. Inc., Rahway, NJ 07065, USA.; El Marrouni A; Discovery Chemistry, Merck & Co. Inc., Rahway, NJ 07065, USA.; Fay JF; Quantitative Biosciences, Merck & Co. Inc., Rahway, NJ 07065, USA.; Forster A; Discovery Chemistry, Merck & Co. Inc., Rahway, NJ 07065, USA.; Goh SL; Quantitative Biosciences, Merck & Co. Inc., Rahway, NJ 07065, USA.; Gu M; Evotec Ltd., Abingdon, Oxfordshire OX14 4RZ, UK.; Krosky D; Quantitative Biosciences, Merck & Co. Inc., Rahway, NJ 07065, USA.; Rosenbloom DIS; Department of Pharmacokinetics, Pharmacodynamics, and Drug Metabolism, Merck & Co. Inc., Rahway, NJ 07065, USA.; Sheth P; Quantitative Biosciences, Merck & Co. Inc., Rahway, NJ 07065, USA.; Wang D; Computational and Structural Chemistry, Merck & Co. Inc., Rahway, NJ, 07065, USA.; Wu G; Infectious Disease and Vaccines, Merck & Co. Inc., Rahway, NJ 07065, USA.; Zebisch M; Evotec Ltd., Abingdon, Oxfordshire OX14 4RZ, UK.; Zhao T; Biostatistics and Research Decision Sciences, Merck & Co. Inc., Rahway, NJ 07065, USA.; Zuck P; Infectious Disease and Vaccines, Merck & Co. Inc., Rahway, NJ 07065, USA.; Grobler J; Infectious Disease and Vaccines, Merck & Co. Inc., Rahway, NJ 07065, USA.; Hazuda DJ; Infectious Disease and Vaccines, Merck & Co. Inc., Rahway, NJ 07065, USA.; Howell BJ; Infectious Disease and Vaccines, Merck & Co. Inc., Rahway, NJ 07065, USA.; Converso A; Discovery Chemistry, Merck & Co. Inc., Rahway, NJ 07065, USA.
Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101505086 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1946-6242 (Electronic) Linking ISSN: 19466234 NLM ISO Abbreviation: Sci Transl Med Subsets: MEDLINE
Academic Journal
Kwon MC; Discovery Oncology, Janssen R&D, Beerse, Belgium.; Thuring JW; Discovery Product Development and Supply, Janssen R&D, Beerse, Belgium.; Querolle O; Discovery Product Development and Supply, Janssen R&D, Beerse, Belgium.; Dai X; Discovery Product Development and Supply, Janssen R&D, Shanghai, China.; Verhulst T; Discovery Oncology, Janssen R&D, Beerse, Belgium.; Pande V; Discovery Product Development and Supply, Janssen R&D, Beerse, Belgium.; Marien A; Discovery Oncology, Janssen R&D, Beerse, Belgium.; Goffin D; Discovery Oncology, Janssen R&D, Beerse, Belgium.; Wenge DV; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA.; Division of Hematology/Oncology, Boston Children's Hospital, and Harvard Medical School, Boston, MA.; Yue H; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA.; Cutler JA; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA.; Division of Hematology/Oncology, Boston Children's Hospital, and Harvard Medical School, Boston, MA.; Jin C; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA.; Perner F; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA.; Division of Hematology/Oncology, Boston Children's Hospital, and Harvard Medical School, Boston, MA.; Hogeling SM; Department of Experimental Hematology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.; Shaffer PL; Discovery Product Development and Supply, Janssen R&D, Spring House, PA.; Jacobs F; Discovery Product Development and Supply, Janssen R&D, Beerse, Belgium.; Vinken P; Discovery Product Development and Supply, Janssen R&D, Beerse, Belgium.; Cai W; Discovery Product Development and Supply, Janssen R&D, Shanghai, China.; Keersmaekers V; Discovery Oncology, Janssen R&D, Beerse, Belgium.; Eyassu F; Discovery Oncology, Janssen R&D, Beerse, Belgium.; Bhogal B; Discovery Product Development and Supply, Janssen R&D, Spring House, PA.; Verstraeten K; Discovery Oncology, Janssen R&D, Beerse, Belgium.; El Ashkar S; Discovery Oncology, Janssen R&D, Beerse, Belgium.; Perry JA; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA.; Division of Hematology/Oncology, Boston Children's Hospital, and Harvard Medical School, Boston, MA.; Jayaguru P; Translational Research, Janssen R&D, Spring House, PA.; Barreyro L; Translational Research, Janssen R&D, Spring House, PA.; Kuchnio A; Discovery Oncology, Janssen R&D, Beerse, Belgium.; Darville N; Discovery Product Development and Supply, Janssen R&D, Beerse, Belgium.; Krosky D; Discovery Product Development and Supply, Janssen R&D, Spring House, PA.; Urbanietz G; Discovery Product Development and Supply, Janssen R&D, Beerse, Belgium.; Verbist B; TMEDS, Janssen R&D, Beerse, Belgium.; Edwards JP; Discovery Product Development and Supply, Janssen R&D, Spring House, PA.; Cowley GS; Discovery Product Development and Supply, Janssen R&D, Spring House, PA.; Kirkpatrick R; Discovery Product Development and Supply, Janssen R&D, Spring House, PA.; Steele R; Discovery Product Development and Supply, Janssen R&D, Spring House, PA.; Ferrante L; Early Development, Janssen R&D, Spring House, PA.; Guttke C; Translational Research, Janssen R&D, Spring House, PA.; Daskalakis N; Early Development, Janssen R&D, Spring House, PA.; Pietsch EC; Discovery Oncology, Janssen R&D, Spring House, PA.; Wilson DM; Discovery Product Development and Supply, Janssen R&D, Beerse, Belgium.; Attar R; Translational Research, Janssen R&D, Spring House, PA.; Elsayed Y; Discovery Oncology, Janssen R&D, Spring House, PA.; Fischer ES; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA.; Schuringa JJ; Department of Experimental Hematology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.; Armstrong SA; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA.; Division of Hematology/Oncology, Boston Children's Hospital, and Harvard Medical School, Boston, MA.; Packman K; Early Development, Janssen R&D, Cambridge, MA.; Philippar U; Discovery Oncology, Janssen R&D, Beerse, Belgium.
Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Krosky, D.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어